James E Ip
Weill Medical College of Cornell University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James E Ip as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:20 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06716021 · ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3Milestone Pharmaceuticals Inc. · recruiting · Atrial Fibrillation · principal investigator
- Ph4NCT03218137 · Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular ContractionsWeill Medical College of Cornell University · recruiting · Premature Ventricular Contraction (PVC) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 65 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:20 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.N Engl J Med · 2015431 citationsRCR 17.4
- A Dual-Chamber Leadless Pacemaker.N Engl J Med · 2023238 citationsRCR 32.1
- First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).Circ Arrhythm Electrophysiol · 202238 citationsRCR 3.1
- 35 citationsRCR 3.6
- 29 citationsRCR 6.4
- Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study.Europace · 202521 citationsRCR 8.6
- Time course of adenosine-induced pulmonary vein reconnection after isolation: implications for mechanism of dormant conduction.Pacing Clin Electrophysiol · 201217 citationsRCR 0.6
- Etripamil Nasal Spray for Conversion of Repeated Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia During Long-Term Follow-Up: Results From the NODE-302 Study.J Am Heart Assoc · 202312 citationsRCR 1.6
- Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201).Circ Arrhythm Electrophysiol · 202312 citationsRCR 1.4
- Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast-Acting, Nondihydropyridine Calcium Channel Blocker.Clin Pharmacol Drug Dev · 202410 citationsRCR 1.6